Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
Is a |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
Is a |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
Is a |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram hydrobromide 10mg/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 2 mg/mL oral solution |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Citalopram hydrobromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |